INTERVIEW: GtreeBNT Looks To Novelty, Deals To Become Dry Eye Player

GtreeBNT is looking to challenge one of the biggest ophthalmology sectors through a novel dry eye syndrome drug with multiple mechanisms of action that the South Korean venture believes can help it carve a significant global niche, helped by international licensing deals.